{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T21:29:02Z","timestamp":1768080542520,"version":"3.49.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1016\/j.ijantimicag.2011.10.014","type":"journal-article","created":{"date-parts":[[2012,1,9]],"date-time":"2012-01-09T16:51:20Z","timestamp":1326127880000},"page":"223-227","source":"Crossref","is-referenced-by-count":17,"title":["Efficacy of intrathecal administration of liposomal amphotericin B combined with voriconazole in a murine model of cryptococcal meningitis"],"prefix":"10.1016","volume":"39","author":[{"given":"Alexandra F.","family":"Gazzoni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Capilla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilio","family":"Mayayo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josep","family":"Guarro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2011.10.014_bib0005","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.clineuro.2009.05.007","article-title":"Unusual presentations of nervous system infection by Cryptococcus neoformans","volume":"111","author":"Eric Searls","year":"2009","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.ijantimicag.2011.10.014_bib0010","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1097\/00002030-200205030-00009","article-title":"Cryptococcal infection in a cohort of HIV-1-infected Ugandan adults","volume":"16","author":"French","year":"2002","journal-title":"AIDS"},{"key":"10.1016\/j.ijantimicag.2011.10.014_bib0015","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1086\/649858","article-title":"Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the Infectious Diseases Society of America","volume":"50","author":"Perfect","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2011.10.014_bib0020","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1159\/000095820","article-title":"Influence of the progression of cryptococcal meningitis on brain penetration and efficacy of AmBisome in a murine model","volume":"52","author":"Takemoto","year":"2006","journal-title":"Chemotherapy"},{"key":"10.1016\/j.ijantimicag.2011.10.014_bib0025","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1056\/NEJM199903113401004","article-title":"Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group","volume":"340","author":"Walsh","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijantimicag.2011.10.014_bib0030","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jinf.2005.04.022","article-title":"Raised intracranial pressure complicating cryptococcal meningitis: immune reconstitution inflammatory syndrome or recurrent cryptococcal disease?","volume":"51","author":"York","year":"2005","journal-title":"J Infect"},{"key":"10.1016\/j.ijantimicag.2011.10.014_bib0035","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1093\/clinids\/23.6.1337-a","article-title":"Possible development of resistance to fluconazole during suppressive therapy for AIDS-associated cryptococcal meningitis","volume":"23","author":"Armengou","year":"1996","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2011.10.014_bib0040","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1128\/AAC.01216-08","article-title":"Antifungal susceptibilities among different serotypes of Cryptococcus gattii and Cryptococcus neoformans","volume":"53","author":"Thompson","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2011.10.014_bib0045","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1128\/JCM.02434-08","article-title":"Activity of contemporary antifungal agents, including the novel echinocandin anidulafungin, tested against Candida spp., Cryptococcus spp., and Aspergillus spp.: report from the SENTRY Antimicrobial Surveillance Program (2006 to 2007)","volume":"47","author":"Messer","year":"2009","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2011.10.014_bib0050","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1128\/AAC.48.6.2014-2020.2004","article-title":"Effects of voriconazole on Cryptococcus neoformans","volume":"48","author":"van Duin","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2011.10.014_bib0055","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1093\/jac\/dkm123","article-title":"Efficacy of voriconazole in a murine model of cryptococcal central nervous system infection","volume":"60","author":"Serena","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2011.10.014_bib0060","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1086\/341567","article-title":"Development of a murine model of cerebral aspergillosis","volume":"186","author":"Chiller","year":"2002","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2011.10.014_bib0065","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1093\/jac\/dkh468","article-title":"A novel murine model of cerebral scedosporiosis: lack of efficacy of amphotericin B","volume":"54","author":"Capilla","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2011.10.014_bib0070","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1093\/jac\/dkg261","article-title":"Improving the mouse model for studying the efficacy of voriconazole","volume":"51","author":"Graybill","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2011.10.014_bib0075","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1136\/jcp.2008.056119","article-title":"Cryptococcus meningitis and skin lesions in an HIV negative child","volume":"61","author":"Swe Han","year":"2008","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.ijantimicag.2011.10.014_bib0080","first-page":"519","article-title":"Cryptococcus neoformans meningitis in a HIV negative miliary tuberculosis-suspected patient","volume":"42","author":"Aydemir","year":"2008","journal-title":"Mikrobiyol Bul"},{"key":"10.1016\/j.ijantimicag.2011.10.014_bib0085","doi-asserted-by":"crossref","first-page":"375","DOI":"10.3201\/eid0703.017302","article-title":"Cryptococcus neoformans infection in organ transplant recipients: variables influencing clinical characteristics and outcome","volume":"7","author":"Husain","year":"2001","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ijantimicag.2011.10.014_bib0090","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1086\/588792","article-title":"High-dose amphotericin B with flucytosine for the treatment of cryptococcal meningitis in HIV-infected patients: a randomized trial","volume":"47","author":"Bicanic","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2011.10.014_bib0095","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1086\/649862","article-title":"Cryptococcosis in the developing world: an elephant in the parlor","volume":"50","author":"Pappas","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2011.10.014_bib0100","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1086\/592117","article-title":"Amphotericin B: the higher the dose, the higher the toxicity","volume":"47","author":"Pasqualotto","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2011.10.014_bib0105","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1086\/313757","article-title":"Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America","volume":"30","author":"Saag","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2011.10.014_bib0110","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1128\/AAC.00085-07","article-title":"New guinea pig model of cryptococcal meningitis","volume":"51","author":"Kirkpatrick","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2011.10.014_bib0115","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s11046-006-0039-4","article-title":"Efficacy of voriconazole in experimental Cryptococcus neoformans infection","volume":"162","author":"Mavrogiorgos","year":"2006","journal-title":"Mycopathologia"},{"key":"10.1016\/j.ijantimicag.2011.10.014_bib0120","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1002\/cncr.22568","article-title":"Monitoring plasma voriconazole levels may be necessary to avoid subtherapeutic levels in hematopoietic stem cell transplant recipients","volume":"109","author":"Trifilio","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.ijantimicag.2011.10.014_bib0125","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1128\/AAC.45.2.612-615.2001","article-title":"Comparative toxicities and pharmacokinetics of intrathecal lipid (amphotericin B colloidal dispersion) and conventional deoxycholate formulations of amphotericin B in rabbits","volume":"45","author":"Clemons","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2011.10.014_bib0130","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1053\/srin.2001.29298","article-title":"Intrathecal amphotericin in the management of coccidioidal meningitis","volume":"16","author":"Stevens","year":"2001","journal-title":"Semin Respir Infect"},{"key":"10.1016\/j.ijantimicag.2011.10.014_bib0135","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1086\/313747","article-title":"Practice guideline for the treatment of coccidioidomycosis. Infectious Diseases Society of America","volume":"30","author":"Galgiani","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2011.10.014_bib0140","first-page":"178","article-title":"Antifungal therapy for treatment of cryptococcal meningitis","volume":"113","author":"Yao","year":"2000","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.ijantimicag.2011.10.014_bib0145","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1086\/377131","article-title":"Voriconazole concentrations in the cerebrospinal fluid and brain tissue of guinea pigs and immunocompromised patients","volume":"37","author":"Lutsar","year":"2003","journal-title":"Clin Infect Dis"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857911004572?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857911004572?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,27]],"date-time":"2018-11-27T07:00:15Z","timestamp":1543302015000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857911004572"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["S0924857911004572"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2011.10.014","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3]]}}}